Clinical Trials List
Protocol NumberIPI-BDH-PK01
2009-03-01 - 2010-12-31
Phase II
Terminated3
-
Trial Applicant
STATPLUS, INC.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Jin-Hwang Liu Division of Hematology & Oncology
- Muh-Hwa Yang Division of Hematology & Oncology
- Chun-Yu Liu Division of Hematology & Oncology
- 曾成槐 Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- Hao-Wei Teng Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Tzeon-jye Chiou Division of Hematology & Oncology
- Ta-Chung Chao Division of Hematology & Oncology
- 洪英中 Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- 余垣斌 Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 湯崇志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shang-Yi Huang Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
0 participants
